or "TMS," is an FDA-approved psychiatric treatment for major depressive disorder and obsessive-compulsive disorder (OCD), with intriguing clinical trials suggesting future application in a variety ...

Several conditions may benefit from TMS therapy. However, only three have been approved by the Food and Drug Administration (FDA): depression, OCD, and nicotine addiction. The FDA indicates that ...

obsessive-compulsive disorder (OCD), anxiety, and post-traumatic stress disorder (PTSD). However, Medicare only covers TMS therapy for the treatment of severe major depressive disorder (MDD).

as well as evidence-based off-label TMS therapy, to patients battling clinical depression, anxiety, OCD, and PTSD. Inspire TMS Denver Inspire TMS Denver's Accelerated TMS treatment allows patients ...

and for the treatment of Obsessive Compulsive Disorder (OCD) in adults aged 22-70. Most major insurances cover NeuroStar TMS, including Medicare and Tricare plans nationwide. New Directions is ...

Inspire TMS Denver transforms mental health care by offering innovative, FDA-approved, as well as evidence-based off-label TMS therapy, to patients battling clinical depression, anxiety, OCD, and PTSD ...

These publications further cement NeuroStar’s position as the leader in advancing TMS therapy and shaping the future of depression treatment.” The following publications highlight key findings ...